NCT04970511

Brief Summary

The aim of our study is to compare the effects of face-to-face and internet-based BBAT in patients diagnosed with Fibromyalgia Syndrome. H0: Face-to-face and internet-based BBAT have superiority over each other in patients diagnosed with Fibromyalgia Syndrome. H1: In patients diagnosed with Fibromyalgia Syndrome, face-to-face and internet-based BBAT have no superiority over each other.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 28, 2021

Completed
3 days until next milestone

Study Start

First participant enrolled

July 1, 2021

Completed
20 days until next milestone

First Posted

Study publicly available on registry

July 21, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2022

Completed
Last Updated

January 9, 2025

Status Verified

December 1, 2024

Enrollment Period

1.5 years

First QC Date

June 28, 2021

Last Update Submit

January 7, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The Revised Fibromyalgia Impact Questionnaire (FIQR)

    Limitations and functional disability in patients with fibromyalgia will be evaluated.

    8 weeks

Secondary Outcomes (10)

  • Algometer

    8 weeks

  • Posture Screen Mobile (PSM)

    8 weeks

  • The short-form McGill Pain Questionnaire

    8 weeks

  • Trunk repositioning error

    8 weeks

  • Awareness-Body-Chart=ABC

    8 weeks

  • +5 more secondary outcomes

Study Arms (3)

The group I: BBAT Face-to-Face Training group

EXPERIMENTAL

Exercises consist of supine, sitting, standing position awareness exercises and walking exercises. Considering eight weeks, the training is designed to progress gradually each week.

Behavioral: BBAT (Basic Body Awareness Therapy)

The group II: Online BBAT training group

EXPERIMENTAL

Patients in the Internet-based BBAT group will conduct their training with a physiotherapist to be connected via an online video conference system. This group will be given the same training as the face-to-face BBAT group.

Behavioral: Online BBAT training

The group III: Control group

NO INTERVENTION

No training will be applied to the control group patients.

Interventions

The group I: BBAT Face-to-Face Training (60 min) will be provided.

The group I: BBAT Face-to-Face Training group

The group II: Online BBAT training (60 min) will be provided.

The group II: Online BBAT training group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • To be between the ages of 18-65
  • Being diagnosed with FMS according to ACR 2016 criteria
  • To be diagnosed with FMS at least 6 months before the study
  • Reported pain intensity \> 4 (Visual Analog Scale 0-10),
  • Individuals that do not have barriers to basic body awareness therapy.

You may not qualify if:

  • Pregnancy or intention to become pregnant within the study period.
  • Substance and alcohol abuse, major psychiatric disorder (preventing compliance), uncontrolled hypertension, diabetes, congestive heart failure, or other serious chronic medical condition that puts the patient at risk for the clinician to expose the patient to potentially serious consequences of their illness
  • Those who have malignancy and those receiving chemotherapy and radiotherapy causing malignancy
  • Those who have suffered from any musculoskeletal, neurological, rheumatological disorder or any condition that may interfere with evaluations (advanced respiratory or orthopedic problems such as fractures, sprains or strains, or spinal surgery) in the past 12 months -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beykent University

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Fibromyalgia

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Özge TAHRAN, MSc

    Beykent University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MSc.,Physiotherapist, Lecturer

Study Record Dates

First Submitted

June 28, 2021

First Posted

July 21, 2021

Study Start

July 1, 2021

Primary Completion

December 20, 2022

Study Completion

December 20, 2022

Last Updated

January 9, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations